<code id='E9DEED7529'></code><style id='E9DEED7529'></style>
    • <acronym id='E9DEED7529'></acronym>
      <center id='E9DEED7529'><center id='E9DEED7529'><tfoot id='E9DEED7529'></tfoot></center><abbr id='E9DEED7529'><dir id='E9DEED7529'><tfoot id='E9DEED7529'></tfoot><noframes id='E9DEED7529'>

    • <optgroup id='E9DEED7529'><strike id='E9DEED7529'><sup id='E9DEED7529'></sup></strike><code id='E9DEED7529'></code></optgroup>
        1. <b id='E9DEED7529'><label id='E9DEED7529'><select id='E9DEED7529'><dt id='E9DEED7529'><span id='E9DEED7529'></span></dt></select></label></b><u id='E9DEED7529'></u>
          <i id='E9DEED7529'><strike id='E9DEED7529'><tt id='E9DEED7529'><pre id='E9DEED7529'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:5627
          Cambridge: AbbVie
          Ruby Wallau for STAT

          AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

          Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

          advertisement

          Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more
          Study suggests new cause of Down syndrome: cells linked to aging
          Study suggests new cause of Down syndrome: cells linked to aging

          NeuralprogenitorcellsderivedfromstemcellsofapersonwithDownsyndrome.CourtesyHiruyMeharenaDownsyndrome

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Louisiana bill approved classifying abortion pills as controlled substances

          AllenG.Breed/APBATONROUGE—Twoabortion-inducingdrugscouldsoonbereclassifiedascontrolledanddangeroussu